Form 8-K GLOBUS MEDICAL INC For: May 02
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Globus Medical (GMED) PT Raised to $58 at Needham & Company
May 3, 2018 6:38 AM EDTNeedham & Company raised its price target on Globus Medical (NYSE: GMED) to $58.00 (from $57.00) while maintaining a Buy rating.
Analyst Mike Matson commented, "GMED's 1Q18 revenue and EPS beat consensus and management raised its 2018 revenue and EPS guidance. The guidance increases were... More
